vs
HF Foods Group Inc.（HFFG）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
HF Foods Group Inc.的季度营收约是Orthofix Medical Inc.的1.4倍（$308.0M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -12.1%，领先11.1%），Orthofix Medical Inc.同比增速更快（2.0% vs 0.9%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $12.1M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 2.1%）
HF Sinclair Corporation是一家总部位于美国得克萨斯州达拉斯的美国能源企业，主要生产并销售汽油、柴油、航空燃油、可再生柴油、特种润滑油产品、特种化学品，以及特种改性沥青等多种能源与化工产品。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HFFG vs OFIX — 直观对比
营收规模更大
HFFG
是对方的1.4倍
$219.9M
营收增速更快
OFIX
高出1.1%
0.9%
净利率更高
OFIX
高出11.1%
-12.1%
自由现金流更多
OFIX
多$4.7M
$12.1M
两年增速更快
OFIX
近两年复合增速
2.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $308.0M | $219.9M |
| 净利润 | $-37.3M | $-2.2M |
| 毛利率 | 16.6% | 71.1% |
| 营业利润率 | -12.8% | 0.2% |
| 净利率 | -12.1% | -1.0% |
| 营收同比 | 0.9% | 2.0% |
| 净利润同比 | 15.0% | 92.4% |
| 每股收益（稀释后） | $-0.70 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HFFGOFIX
| Q4 25 | $308.0M | $219.9M | ||
| Q3 25 | $307.0M | $205.6M | ||
| Q2 25 | $314.9M | $203.1M | ||
| Q1 25 | $298.4M | $193.6M | ||
| Q4 24 | $305.3M | $215.7M | ||
| Q3 24 | $298.4M | $196.6M | ||
| Q2 24 | $302.3M | $198.6M | ||
| Q1 24 | $295.7M | $188.6M |
净利润HFFGOFIX
| Q4 25 | $-37.3M | $-2.2M | ||
| Q3 25 | $-1.1M | $-22.8M | ||
| Q2 25 | $1.2M | $-14.1M | ||
| Q1 25 | $-1.6M | $-53.1M | ||
| Q4 24 | $-43.9M | $-29.1M | ||
| Q3 24 | $-3.9M | $-27.4M | ||
| Q2 24 | $17.0K | $-33.4M | ||
| Q1 24 | $-694.0K | $-36.0M |
毛利率HFFGOFIX
| Q4 25 | 16.6% | 71.1% | ||
| Q3 25 | 16.4% | 72.2% | ||
| Q2 25 | 17.5% | 68.7% | ||
| Q1 25 | 17.1% | 62.8% | ||
| Q4 24 | 17.1% | 69.0% | ||
| Q3 24 | 16.8% | 68.7% | ||
| Q2 24 | 17.4% | 67.8% | ||
| Q1 24 | 17.1% | 67.5% |
营业利润率HFFGOFIX
| Q4 25 | -12.8% | 0.2% | ||
| Q3 25 | 0.4% | -8.3% | ||
| Q2 25 | 1.3% | -7.9% | ||
| Q1 25 | 0.4% | -25.2% | ||
| Q4 24 | -13.8% | -5.3% | ||
| Q3 24 | 0.2% | -9.6% | ||
| Q2 24 | 0.9% | -12.5% | ||
| Q1 24 | -0.0% | -15.6% |
净利率HFFGOFIX
| Q4 25 | -12.1% | -1.0% | ||
| Q3 25 | -0.4% | -11.1% | ||
| Q2 25 | 0.4% | -6.9% | ||
| Q1 25 | -0.6% | -27.4% | ||
| Q4 24 | -14.4% | -13.5% | ||
| Q3 24 | -1.3% | -13.9% | ||
| Q2 24 | 0.0% | -16.8% | ||
| Q1 24 | -0.2% | -19.1% |
每股收益（稀释后）HFFGOFIX
| Q4 25 | $-0.70 | $-0.05 | ||
| Q3 25 | $-0.02 | $-0.57 | ||
| Q2 25 | $0.02 | $-0.36 | ||
| Q1 25 | $-0.03 | $-1.35 | ||
| Q4 24 | $-0.84 | $-0.76 | ||
| Q3 24 | $-0.07 | $-0.71 | ||
| Q2 24 | $0.00 | $-0.88 | ||
| Q1 24 | $-0.01 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | $106.1M | — |
| 股东权益账面价值 | $202.1M | $450.0M |
| 总资产 | $541.5M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.53× | — |
8季度趋势，按日历期对齐
现金及短期投资HFFGOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | — | $27.0M |
总债务HFFGOFIX
| Q4 25 | $106.1M | — | ||
| Q3 25 | $107.3M | $157.2M | ||
| Q2 25 | $106.0M | $157.0M | ||
| Q1 25 | $107.4M | $156.9M | ||
| Q4 24 | $108.7M | $157.0M | ||
| Q3 24 | $110.1M | $118.5M | ||
| Q2 24 | $111.4M | $118.0M | ||
| Q1 24 | $112.8M | $118.2M |
股东权益HFFGOFIX
| Q4 25 | $202.1M | $450.0M | ||
| Q3 25 | $239.2M | $442.5M | ||
| Q2 25 | $239.7M | $458.3M | ||
| Q1 25 | $238.0M | $458.3M | ||
| Q4 24 | $239.3M | $503.1M | ||
| Q3 24 | $283.1M | $525.9M | ||
| Q2 24 | $286.3M | $546.0M | ||
| Q1 24 | $286.7M | $570.3M |
总资产HFFGOFIX
| Q4 25 | $541.5M | $850.6M | ||
| Q3 25 | $595.1M | $832.6M | ||
| Q2 25 | $593.5M | $837.2M | ||
| Q1 25 | $581.9M | $823.1M | ||
| Q4 24 | $550.0M | $893.3M | ||
| Q3 24 | $612.8M | $867.9M | ||
| Q2 24 | $616.9M | $882.0M | ||
| Q1 24 | $603.1M | $906.0M |
负债/权益比HFFGOFIX
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.45× | 0.36× | ||
| Q2 25 | 0.44× | 0.34× | ||
| Q1 25 | 0.45× | 0.34× | ||
| Q4 24 | 0.45× | 0.31× | ||
| Q3 24 | 0.39× | 0.23× | ||
| Q2 24 | 0.39× | 0.22× | ||
| Q1 24 | 0.39× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $12.1M | $16.8M |
| 自由现金流率自由现金流/营收 | 3.9% | 7.6% |
| 资本支出强度资本支出/营收 | 2.9% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.6M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HFFGOFIX
| Q4 25 | $21.0M | $27.7M | ||
| Q3 25 | $-6.0M | $12.4M | ||
| Q2 25 | $3.5M | $11.6M | ||
| Q1 25 | $6.9M | $-18.4M | ||
| Q4 24 | $18.4M | $23.7M | ||
| Q3 24 | $2.3M | $11.7M | ||
| Q2 24 | $-9.3M | $9.0M | ||
| Q1 24 | $11.2M | $-18.6M |
自由现金流HFFGOFIX
| Q4 25 | $12.1M | $16.8M | ||
| Q3 25 | $-9.3M | $2.5M | ||
| Q2 25 | $363.0K | $4.5M | ||
| Q1 25 | $3.4M | $-25.1M | ||
| Q4 24 | $15.3M | $15.2M | ||
| Q3 24 | $-820.0K | $6.3M | ||
| Q2 24 | $-13.0M | $-360.0K | ||
| Q1 24 | $8.6M | $-29.1M |
自由现金流率HFFGOFIX
| Q4 25 | 3.9% | 7.6% | ||
| Q3 25 | -3.0% | 1.2% | ||
| Q2 25 | 0.1% | 2.2% | ||
| Q1 25 | 1.1% | -13.0% | ||
| Q4 24 | 5.0% | 7.0% | ||
| Q3 24 | -0.3% | 3.2% | ||
| Q2 24 | -4.3% | -0.2% | ||
| Q1 24 | 2.9% | -15.4% |
资本支出强度HFFGOFIX
| Q4 25 | 2.9% | 4.9% | ||
| Q3 25 | 1.1% | 4.8% | ||
| Q2 25 | 1.0% | 3.5% | ||
| Q1 25 | 1.2% | 3.5% | ||
| Q4 24 | 1.0% | 4.0% | ||
| Q3 24 | 1.0% | 2.7% | ||
| Q2 24 | 1.2% | 4.7% | ||
| Q1 24 | 0.9% | 5.6% |
现金转化率HFFGOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.89× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -546.06× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HFFG
| Seafood | $110.2M | 36% |
| Meat And Poultry | $62.7M | 20% |
| Asian Specialty | $55.3M | 18% |
| Commodity Product | $35.1M | 11% |
| Fresh Produce | $29.9M | 10% |
| Packaging And Other | $14.7M | 5% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
